2025. 12. 10
New C2H Report: Capivasertib (Truqap)
2025. 11. 14
New C2H Report: Elranatamab (Elrexfio)
2025. 10. 15
New C2H Report: Zolbetuximab (Vyloy)
View all news
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events